INMED PHARMACEUTICALS INC. Earnings Per Share, Basic and Diluted
INMED PHARMACEUTICALS INC. (INM) reported Earnings Per Share, Basic and Diluted of -$0.31 per share for the 3-month period ending 2021-12-31, per its 10-Q filed 2022-02-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-02-14
- INMED PHARMACEUTICALS INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.31.
- INMED PHARMACEUTICALS INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.25.
- INMED PHARMACEUTICALS INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.41.
- INMED PHARMACEUTICALS INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.37.
- INMED PHARMACEUTICALS INC. earnings per share, basic and diluted for fiscal 2021 was -$1.52.
- INMED PHARMACEUTICALS INC. earnings per share, basic and diluted for fiscal 2020 was -$1.71.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$0.31 10-Q · filed 2022-02-14 | -$0.56 10-Q · filed 2022-02-14 | ||
| 2021-09-30 | -$0.25 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | -$1.52 10-K · filed 2021-09-24 | |||
| 2021-03-31 | -$0.41 10-Q · filed 2021-05-13 | -$1.11 10-Q · filed 2021-05-13 | ||
| 2020-12-31 | -$0.37 10-Q · filed 2022-02-14 | -$0.68 10-Q · filed 2022-02-14 | ||
| 2020-09-30 | -$0.31 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | -$1.71 10-K · filed 2021-09-24 | |||
| 2020-03-31 | -$0.39 10-Q · filed 2021-05-13 | -$1.40 10-Q · filed 2021-05-13 | ||
| 2019-12-31 | -$0.48 10-Q · filed 2021-02-11 | -$1.01 10-Q · filed 2021-02-11 | ||
| 2019-09-30 | -$0.54 10-Q · filed 2020-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |